Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$831M |
| 2 |
Palo Alto Networks
PANW
|
$348M |
| 3 |
Visa
V
|
$347M |
| 4 |
Citigroup
C
|
$296M |
| 5 |
CELG
Celgene Corp
CELG
|
$295M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$638M |
| 2 |
EOG Resources
EOG
|
$322M |
| 3 |
Canadian Pacific Kansas City
CP
|
$305M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$289M |
| 5 |
JD.com
JD
|
$283M |
Sector Composition
| 1 | Healthcare | 19.11% |
| 2 | Consumer Discretionary | 17.28% |
| 3 | Communication Services | 14.32% |
| 4 | Technology | 13.24% |
| 5 | Financials | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFMD
501
DELISTED
Affimed
AFMD
| $10M | 0.01% |
162,061
-2,736
| -2% | -$169K |
|
502
Glaukos
GKOS
$5.29B
| $9.75M | 0.01% |
403,215
-177,415
| -31% | -$4.29M |
|
503
Renasant Corp
RNST
$3.74B
| $9.64M | 0.01% |
293,456
+202,100
| +221% | +$6.64M |
|
|
TVRD
504
Tvardi Therapeutics, Inc. Common Stock
TVRD
$289M
| $9.35M | 0.01% |
18,179
+11,900
| +190% | +$6.12M |
|
505
Xencor
XNCR
$598M
| $9.13M | 0.01% |
746,762
-8,743
| -1% | -$107K |
|
|
WBC
506
DELISTED
WABCO HOLDINGS INC.
WBC
| $9.03M | 0.01% |
86,153
-2,256
| -3% | -$236K |
|
|
AGTC
507
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $8.86M | 0.01% |
674,362
-367,461
| -35% | -$4.83M |
|
508
Standard BioTools
LAB
$527M
| $8.82M | 0.01% |
1,087,650
-1,753,598
| -62% | -$14.2M |
|
509
Oneok
OKE
$45.1B
| $8.48M | 0.01% |
+263,407
| New | +$8.48M |
|
510
Salarius Pharmaceuticals
SLRX
$2.36M
| $7.89M | 0.01% |
9
-1
| -10% | -$876K |
|
511
Regenxbio
RGNX
$485M
| $7.67M | 0.01% |
+355,344
| New | +$7.67M |
|
|
ACGN
512
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $7.27M | 0.01% |
15,973
+94
| +0.6% | +$42.8K |
|
|
TRVN
513
DELISTED
Trevena, Inc.
TRVN
| $7.25M | 0.01% |
+1,120
| New | +$7.25M |
|
514
Coherus Oncology, Inc. Common Stock
CHRS
$158M
| $7.13M | 0.01% |
355,998
+2,635
| +0.7% | +$52.8K |
|
515
Qualys
QLYS
$4.83B
| $7.12M | 0.01% |
250,263
-8,800
| -3% | -$250K |
|
|
AGN.PRA
516
DELISTED
Allergan plc.
AGN.PRA
| $7.08M | 0.01% |
7,500
| – | – |
|
|
ALPN
517
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $7.07M | 0.01% |
137,887
-6,409
| -4% | -$329K |
|
|
BPL
518
DELISTED
Buckeye Partners, L.P.
BPL
| $6.98M | 0.01% |
117,842
+52,724
| +81% | +$3.12M |
|
|
TEP
519
DELISTED
Tallgrass Energy Partners, LP
TEP
| $6.8M | 0.01% |
173,049
+36,212
| +26% | +$1.42M |
|
|
GNMX
520
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $6.58M | 0.01% |
841,959
+165,089
| +24% | +$1.29M |
|
|
CNCE
521
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $6.33M | 0.01% |
337,193
+2,507
| +0.7% | +$47.1K |
|
|
CSII
522
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.98M | 0.01% |
377,752
-95,079
| -20% | -$1.51M |
|
|
ADAP
523
Adaptimmune Therapeutics
ADAP
$11.6M
| $5.81M | 0.01% |
485,401
+135,401
| +39% | +$1.62M |
|
|
PRTK
524
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $5.76M | 0.01% |
303,048
+1,534
| +0.5% | +$29.1K |
|
525
MacroGenics
MGNX
$114M
| $5.71M | 0.01% |
266,499
+176,443
| +196% | +$3.78M |
|